From: Lung function and the risk of frailty in the European population: a mendelian randomization study
Exposure | Method | Frailty (outcome) | |||
---|---|---|---|---|---|
Beta | P | Cochran Q | MR-Egger intercept (P) | ||
FEV1 | MR-PRESSO Raw | ā0.08 | 3.11Eā05 | 370.72 | 0.354 |
MR-PRESSO Outlier-corrected | ā0.07 | 7.70Eā05 | |||
FEV1/FVC | MR-PRESSO Raw | ā0.06 | 1.43Eā05 | 394.62 | 0.883 |
MR-PRESSO Outlier-corrected | ā0.06 | 9.24Eā06 | |||
FVC | MR-PRESSO Raw | ā0.01 | 0.682 | 347.28 | 0.602 |
MR-PRESSO Outlier-corrected | ā0.00 | 0.865 | |||
PEF | MR-PRESSO Raw | ā0.07 | 5.40Eā04 | 284.76 | 0.056 |
MR-PRESSO Outlier-corrected | ā0.07 | 1.48Eā04 |